Palisade Bio (PALI) Change in Accured Expenses (2010 - 2026)

Palisade Bio (PALI) has 17 years of Change in Accured Expenses data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 524.17% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 4089.47% increase from a year earlier, with the FY2025 full-year figure at $624000.0, up 1214.29% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $2.6 million, up from $369000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for PALI reached as high as $2.6 million in Q1 2026 and fell as low as -$604000.0 in Q1 2025.
• Historically, Change in Accured Expenses has averaged $178647.1 across 5 years, with a median of $17000.0 in 2022.
• Across the five-year window, Change in Accured Expenses sank 637.5% in 2022 and jumped 3825.0% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $817000.0 in 2022, then tumbled by 165.48% to -$535000.0 in 2023, then decreased by 8.79% to -$582000.0 in 2024, then jumped by 163.4% to $369000.0 in 2025, then jumped by 594.31% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $2.6 million in Q1 2026, $369000.0 in Q4 2025, and $785000.0 in Q3 2025.